Immunogen (IMGN) Misses Q1 EPS Views; Revenue Light of Consensus
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
EPS Growth %: +100.0%
Financial Fact:
Total operating expenses: 46.5M
Today's EPS Names:
RUSHA, SEIC, OSBC, More
EPS Growth %: +100.0%
Financial Fact:
Total operating expenses: 46.5M
Today's EPS Names:
RUSHA, SEIC, OSBC, More
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q1 EPS of ($0.51), $0.13 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $7.66 million versus the consensus estimate of $21.12 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- United Community Banks (UCBI) Tops Q1 EPS by 2c
- Ribbon Communications (RBBN) Misses Q1 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
